Jared Holz, Mizuho Securities healthcare sector strategist, joins ‘The Exchange’ to discuss Insmed’s lung drug being greenlit by the FDA and his read on the healthcare sector.
04:38
Thu, Aug 14 20251:38 PM EDT
We got it fixed,
Jared Holz, Mizuho Securities healthcare sector strategist, joins ‘The Exchange’ to discuss Insmed’s lung drug being greenlit by the FDA and his read on the healthcare sector.
04:38
Thu, Aug 14 20251:38 PM EDT